Literature DB >> 35782249

Relative basal myocardial weakness: differentiating dermatomyositis and polymyositis with cardiac involvement from viral myocarditis using speckle-tracking echocardiography and quantification of myocardial work.

Xiaohang Liu1, Fan Jin2, Tianchen Guo1, Qian Wang3, Ligang Fang1, Wei Chen1.   

Abstract

Background: Both viral infection and autoimmune diseases like dermatomyositis (DM) and polymyositis (PM) can cause myocarditis and inflammatory cardiomyopathy. It is of great importance to identify underlying etiologies and initiate appropriate treatment. This study aimed to describe the pattern of regional longitudinal strain (LS) and myocardial work in PM/DM patients with cardiac involvement and investigate the usefulness of the pattern to differentiate PM/DM from acute viral myocarditis (AVM) in the clinical setting.
Methods: A total of 46 PM/DM patients with cardiac involvement, 24 patients with AVM, and 30 healthy control participants (HCs) were included. Regional myocardial work and strain analyses were performed using two-dimensional (2D) echocardiography to calculate relative basal LS and myocardial work parameters and investigate their value for differential diagnosis.
Results: PM and DM are characterized by a pattern of basal myocardial weakness with LS (basal, mid, and apical segments: -15.0±4.4, -17.1±4.7, and -21.4±6.5, respectively), myocardial work index (basal, mid, and apical segments: 1,193±432, 1,272±394, and 1,431±451, respectively), and constructive work (basal, mid, and apical segments: 1,512±422, 1,628±413, and 1,912±433, respectively) that show a base-to-apex gradient in which the myocardium at the base is more severely injured that that of the apex. On cardiovascular magnetic resonance, the positive rate of late gadolinium enhancement was also significantly higher in the basal segments (64%) than the mid (44%) and apical (28%) segments (P=0.038). A relative basal LS of 0.43, defined using the equation [average basal LS/(average mid LS + average apical LS)], had an area under curve (AUC) of 0.88 with high sensitivity (88%) and specificity (78%) to differentiate PM/DM from AVM. Using multivariate logistic regression analysis, relative basal injury of myocardium and creatine kinase elevation were strongly correlated with proximal skeletal muscle weakness according to manual muscle testing (P=0.036 and P=0.010, respectively). Conclusions: Similar to the typical proximal muscle weakness of limbs, PM/DM patients also presented with regionally decreased LS and myocardial work of the basal myocardium. A "basal weakness" pattern is easily recognizable and can be used to accurately differentiate PM/DM with cardiac involvement from AVM. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Relative basal myocardial weakness; dermatomyositis and polymyositis (DM and PM); echocardiographic strain analysis; myocardial work; viral myocarditis

Year:  2022        PMID: 35782249      PMCID: PMC9246726          DOI: 10.21037/qims-21-1098

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  38 in total

1.  Myocardial work by echocardiography: a novel method ready for clinical testing.

Authors:  Espen Boe; Helge Skulstad; Otto A Smiseth
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-01-01       Impact factor: 6.875

2.  Myocardial Work in Nonobstructive Hypertrophic Cardiomyopathy: Implications for Outcome.

Authors:  Yasmine L Hiemstra; Pieter van der Bijl; Mohammed El Mahdiui; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  J Am Soc Echocardiogr       Date:  2020-07-14       Impact factor: 5.251

Review 3.  Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations.

Authors:  Vanessa M Ferreira; Jeanette Schulz-Menger; Godtfred Holmvang; Christopher M Kramer; Iacopo Carbone; Udo Sechtem; Ingrid Kindermann; Matthias Gutberlet; Leslie T Cooper; Peter Liu; Matthias G Friedrich
Journal:  J Am Coll Cardiol       Date:  2018-12-18       Impact factor: 24.094

4.  The 4D B-spline method of calculating left ventricular functional parameters of cardiac MRI to evaluate myocardial injury of the apical segment in patients with myocarditis: a case-controlled observational study.

Authors:  Xin-Xiang Zhao; Wei-Feng Yuan
Journal:  Quant Imaging Med Surg       Date:  2020-11

Review 5.  Proximal myopathy: diagnostic approach and initial management.

Authors:  Ernest Suresh; Sunil Wimalaratna
Journal:  Postgrad Med J       Date:  2013-04-17       Impact factor: 2.401

6.  Utility of strain-echocardiography in current clinical practice.

Authors:  Kaoru Dohi; Emiyo Sugiura; Masaaki Ito
Journal:  J Echocardiogr       Date:  2016-03-02

Review 7.  Update on Myocarditis and Inflammatory Cardiomyopathy: Reemergence of Endomyocardial Biopsy.

Authors:  Fernando Dominguez; Uwe Kühl; Burkert Pieske; Pablo Garcia-Pavia; Carsten Tschöpe
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2016-01-12

8.  Speckle tracking echocardiography in acute lupus myocarditis: comparison to conventional echocardiography.

Authors:  Riëtte Du Toit; Phillip G Herbst; Annari van Rensburg; Hendrik W Snyman; Helmuth Reuter; Anton F Doubell
Journal:  Echo Res Pract       Date:  2017-05-10

Review 9.  Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update : Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing.

Authors:  Jeanette Schulz-Menger; David A Bluemke; Jens Bremerich; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Raymond J Kim; Florian von Knobelsdorff-Brenkenhoff; Christopher M Kramer; Dudley J Pennell; Sven Plein; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2020-03-12       Impact factor: 5.364

10.  Myocardial work in hypertensive patients with and without diabetes: An echocardiographic study.

Authors:  Marijana Tadic; Cesare Cuspidi; Biljana Pencic; Guido Grassi; Vera Celic
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.